Skip to main content

Find Clinical Trials

Home
Conditions
Sexually Transmitted Diseases

Clinical trial condition

Sexually Transmitted Diseases

Explore clinical trials studying Sexually Transmitted Diseases. Study availability and eligibility vary by location and protocol.

6,133 public trials 372 recruiting studies

Refine in advanced search Browse all conditions

Sexually Transmitted Diseases trial results

Completed

Human Papillomavirus (HPV) Vaccine (Cervarix TM) Efficacy, Immunogenicity & Safety Trial in Adult Japanese Women With GSK Biologicals HPV-16/18 Vaccine

NCT00316693

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +11 more
Locations: GSK Investigational Site Kagoshima, Japan

GSK Investigational Site Tokyo, Japan

GSK Investigational Site Tokyo, Japan

GSK Investigational Site

View Trial Details

Completed

Immunogenicity and Safety of GSK Biologicals' HPV Vaccine 580299 in Healthy Japanese Females 10-15 Years of Age

NCT00492544

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +22 more
Locations: GSK Investigational Site Saitama, Japan

GSK Investigational Site Saitama, Japan

GSK Investigational Site Tokyo, Japan

GSK Investigational Site Tokyo, Japan

View Trial Details

Completed

The Effect of Antacids on the Pharmacokinetics (PK) of Raltegravir in Human Immunodeficiency Virus (HIV)-Infected Participants (MK-0518-824)

NCT02473367

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis

NCT02165202

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: New Jersey Medical School Clinical Research Center Newark, New Jersey, United States

Bronx Prevention Center The Bronx, New York, United States

Emavundleni Clinical Research Site Cape Town, South Africa

Spilhaus Clinical Research Site Belgravia, Harare, Zimbabwe

View Trial Details

Completed

A Pharmacokinetic Study to Evaluate the Effect of MAALOX on Raltegravir (MK-0518) in Human Immunodeficiency Virus (HIV)-Infected Participants (MK-0518-295)

NCT01930045

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Not specified

View Trial Details

Completed

An Investigational Study of Gardasil™ (qHPV Vaccine) in Reducing the Incidence of Anogenital Warts in Young Men (V501-020)

NCT00090285

Conditions: Communicable Diseases, Condylomata Acuminata, DNA Virus Infections, +16 more
Locations: Not specified

View Trial Details

Completed

Causes of Rotavirus Vaccine Failure in Zambian Children

NCT01886833

Conditions: Blood-Borne Infections, Communicable Diseases, Diarrhea, +17 more
Locations: Centre for Infectious Disease Research in Zambia Lusaka, Zambia

View Trial Details

Completed

3BNC117 and 10-1074 in HIV-infected Individuals

NCT02825797

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: The Rockefeller University New York, United States

University Hospital of Cologne Cologne, Germany

View Trial Details

Completed

A Study of the Safety, Tolerability, and Antiretroviral Activity of Raltegravir (MK-0518) in Combination With Other Antiretroviral Therapies in Russian Children and Adolescents Infected With Human Immunodeficiency Virus (HIV-1) (MK-0518-248)

NCT01717287

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18

NCT00122681

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +11 more
Locations: GSK Investigational Site Birmingham, Alabama, United States

GSK Investigational Site Fountain Valley, California, United States

GSK Investigational Site San Diego, California, United States

GSK Investigational Site San Francisco, California, United States

View all 138 locations

View Trial Details